Baseline characteristics of phase 3 randomized controlled trials of omalizumab in chronic rhinosinusitis with nasal polyps Meeting Abstract

publication date

  • August 1, 2019

webpage

published in

start page

  • 329

end page

  • 330

volume

  • 74